Tania Konry, Ph.D- Founder: Dr. Konry was trained by leading experts in assay development and bioengineering (David Walt, cofounder of Illumina and Martin Yarmush/ Harvard University). She is the inventor of the Kytaro’s technology and her laboratory at Northeastern University is focused on developing novel Bio-MEMS approaches to advance personalized medicine, diagnostics, immunotherapy and drug screening.

Dr. Gelber held various executive positions in academia (Duke University) and biopharmaceutical companies (ImmuLogic Pharmaceutical Corporation, Molecular Discoveries and MannKind Corporation). Served as Chief Scientific & Technology Officer of ATCC. Dr. Gelber is the founder of 6 biotechnology companies and currently is the Executive Chairperson of the board of Serpin Pharma and a board member in Orpheus, Stromatis and Monet Pharmaceuticals.

Leads the recruitment, translational research commercialization, and tenant graduation for Prince William Science Accelerator. Works with 10+ life science startups that have raised over $30 million in dilutive and non-dilutive funding.